HC Wainwright reissued their buy rating on shares of Aemetis (NASDAQ:AMTX – Free Report) in a report released on Monday morning,Benzinga reports. HC Wainwright currently has a $28.00 price objective on the specialty chemicals company’s stock.
Separately, Ascendiant Capital Markets cut their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $12.95.
Read Our Latest Analysis on Aemetis
Aemetis Price Performance
Aemetis (NASDAQ:AMTX – Get Free Report) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period last year, the business posted ($0.59) EPS. As a group, equities analysts anticipate that Aemetis will post -2.02 EPS for the current year.
Hedge Funds Weigh In On Aemetis
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC raised its position in Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after buying an additional 66,031 shares during the last quarter. State Street Corp raised its holdings in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its position in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. Bank of New York Mellon Corp purchased a new stake in Aemetis in the 2nd quarter valued at approximately $306,000. Finally, Wellington Management Group LLP acquired a new position in Aemetis during the 3rd quarter worth approximately $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.
Aemetis Company Profile
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
- Five stocks we like better than Aemetis
- Trading Halts Explained
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is the Nasdaq? Complete Overview with History
- 2 Drone Stocks Surging from Increased Media Attention
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.